Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

PSNC's Sue Sharpe to resign at end of 2017

Pharmaceutical Services Negotiating Committee (PSNC) chief executive Sue Sharpe will resign at the end of the year, the negotiator has announced.

Ms Sharpe made the announcement at PSNC's May meeting in London, it posted on its website this afternoon (May 9).

She has held the role since 2001, the negotiator pointed out.

PSNC told C+D it could not comment on the reason for Ms Sharpe's departure or who will replace her.

The Twitter reaction
The NPA's reaction

National Pharmacy Association (NPA) chairman Ian Strachan said the organisation was “indebted” to Ms Sharpe for her years of “tireless service” in the sector.

“Sue stands out as someone who knows how to operate within the corridors of Whitehall, yet also understands the pharmacy frontline and cares deeply about what happens to contractors, pharmacy staff and patients,” Mr Strachan said.

"She is an exceptionally capable leader who will be sorely missed," he added.

What do you make of Ms Sharpe's resignation?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008730

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel